Cargando…

Acute exacerbation in interstitial lung disease

BACKGROUND: Information regarding acute exacerbation (AE) in patients with interstitial lung disease (ILD) is limited. OBJECTIVES: The objective of the study was to elucidate the clinical features and outcome of AE among ILD patients. METHODS: We retrospectively analyzed the data of 667 consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhamad, Esam H., Cal, Joseph G., Alrajhi, Nuha N., AlBoukai, Ahmad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109689/ https://www.ncbi.nlm.nih.gov/pubmed/34012485 http://dx.doi.org/10.4103/atm.atm_14_21

Ejemplares similares

Clinical characteristics and outcomes in patients with primary Sjogren's syndrome-associated interstitial lung disease
por: Alhamad, Esam H., et al.
Publicado: (2021)

Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis
por: Alhamad, Esam H., et al.
Publicado: (2020)

Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension
por: Alhamad, Esam H., et al.
Publicado: (2020)

Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis
por: Alhamad, Esam H, et al.
Publicado: (2013)

Pulmonary hypertension in Saudi Arabia: A single center experience
por: Alhamad, Esam H., et al.
Publicado: (2013)

Predictors of mortality in interstitial lung disease patients without pulmonary hypertension
por: Alhamad, Esam H., et al.
Publicado: (2020)

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: Unusual presentation
por: Alrajhi, Nuha Nasser, et al.
Publicado: (2019)

Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients
por: Alhamad, Esam H., et al.
Publicado: (2010)

Interstitial lung diseases in Saudi Arabia: A single-center study
por: Alhamad, Esam H.
Publicado: (2013)

Familial interstitial lung disease in four members of one family: a case series
por: Alhamad, Esam H
Publicado: (2009)

Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017)

A study of chronic obstructive pulmonary disease-specific causes of osteoporosis with emphasis on the emphysema phenotype
por: Fouda, Mona Ali, et al.
Publicado: (2017)

Endobronchial biopsy in the final diagnosis of chronic obstructive pulmonary disease and asthma: a clinicopathological study
por: Arafah, Maria Abdulrahim, et al.
Publicado: (2018)

COVID-19 and acute exacerbation of interstitial lung disease
por: Kondoh, Yasuhiro, et al.
Publicado: (2021)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2023)

Acute exacerbation of interstitial lung disease in the intensive care unit
por: Charokopos, Antonios, et al.
Publicado: (2022)

Prevalence of viral infection in acute exacerbation of interstitial lung diseases in Japan
por: On, Rintaro, et al.
Publicado: (2020)

Acute exacerbations of interstitial lung disease: what is the best treatment?
por: Meyer, Keith C.
Publicado: (2021)

Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases
por: Ito, Yoko, et al.
Publicado: (2019)

LBODP017 Unusual Presentation Of Brown Tumors In Tertiary Hyperparathyroidism: A Case-based Review
por: ALShehri, Sara Mohammed, et al.
Publicado: (2022)

Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease
por: Isshiki, Takuma, et al.
Publicado: (2022)

Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
por: Sekine, Akimasa, et al.
Publicado: (2022)

Cyclophosphamide for the treatment of Acute Exacerbation of Interstitial Lung Disease: A Review of the Literature
por: Innabi, Ayoub, et al.
Publicado: (2021)

Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
por: Takahara, Yutaka, et al.
Publicado: (2021)

Acute Exacerbation of Interstitial Lung Disease as a Sequela of COVID-19 Pneumonia
por: Fonseca, Mario, et al.
Publicado: (2021)

Combined ultrasound–CT approach to monitor acute exacerbation of interstitial lung disease
por: Mongodi, Silvia, et al.
Publicado: (2020)

Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Secondary analysis of preoperative predictors for acute postoperative exacerbation in interstitial lung disease
por: Seto, Fumiko, et al.
Publicado: (2023)

Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease
por: León Román, Francisco, et al.
Publicado: (2023)

The effects of direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute exacerbation of interstitial lung disease
por: Lee, Jae Ha, et al.
Publicado: (2021)

Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis
por: Wu, Tingting, et al.
Publicado: (2022)

Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
por: Jang, Hye Jin, et al.
Publicado: (2021)

Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Faverio, Paola, et al.
Publicado: (2021)

Predictors of postoperative acute exacerbation of interstitial lung disease: a case–control study
por: Hosoki, Keisuke, et al.
Publicado: (2020)

Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases
por: Saraya, Takeshi, et al.
Publicado: (2018)

Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination
por: Sakayori, Masashi, et al.
Publicado: (2023)

Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease
por: Salonen, Johanna, et al.
Publicado: (2023)

Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world
por: Kato, Motoyasu, et al.
Publicado: (2023)

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
por: Kobayashi, Haruki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d6lgcqhcvjb5na30pb8m7i1alt